BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 27058149)

  • 1. P2Y13 receptors mediate presynaptic inhibition of acetylcholine release induced by adenine nucleotides at the mouse neuromuscular junction.
    Guarracino JF; Cinalli AR; Fernández V; Roquel LI; Losavio AS
    Neuroscience; 2016 Jun; 326():31-44. PubMed ID: 27058149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous purines modulate K
    Guarracino JF; Cinalli AR; Veggetti MI; Losavio AS
    J Neurosci Res; 2018 Jun; 96(6):1066-1079. PubMed ID: 29436006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presynaptic inhibition of spontaneous acetylcholine release mediated by P2Y receptors at the mouse neuromuscular junction.
    De Lorenzo S; Veggetti M; Muchnik S; Losavio A
    Neuroscience; 2006 Sep; 142(1):71-85. PubMed ID: 16843602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of purines on calcium-independent acetylcholine release at the mouse neuromuscular junction.
    Veggetti M; Muchnik S; Losavio A
    Neuroscience; 2008 Jul; 154(4):1324-36. PubMed ID: 18534762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inosine induces presynaptic inhibition of acetylcholine release by activation of A3 adenosine receptors at the mouse neuromuscular junction.
    Cinalli AR; Guarracino JF; Fernandez V; Roquel LI; Losavio AS
    Br J Pharmacol; 2013 Aug; 169(8):1810-23. PubMed ID: 23731236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of endogenous purines on electrically evoked ACh release at the mouse neuromuscular junction.
    González Sanabria J; Hurtado Paso M; Frontera T; Losavio A
    J Neurosci Res; 2022 Oct; 100(10):1933-1950. PubMed ID: 35839285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presynaptic inhibition of spontaneous acetylcholine release induced by adenosine at the mouse neuromuscular junction.
    De Lorenzo S; Veggetti M; Muchnik S; Losavio A
    Br J Pharmacol; 2004 May; 142(1):113-24. PubMed ID: 15066904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of neurotransmitter release by P2X and P2Y receptors in the rat spinal cord.
    Heinrich A; Kittel A; Csölle C; Sylvester Vizi E; Sperlágh B
    Neuropharmacology; 2008 Feb; 54(2):375-86. PubMed ID: 18063000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenine nucleotides inhibit recombinant N-type calcium channels via G protein-coupled mechanisms in HEK 293 cells; involvement of the P2Y13 receptor-type.
    Wirkner K; Schweigel J; Gerevich Z; Franke H; Allgaier C; Barsoumian EL; Draheim H; Illes P
    Br J Pharmacol; 2004 Jan; 141(1):141-51. PubMed ID: 14662731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The involvement of P2Y12 receptors, NADPH oxidase, and lipid rafts in the action of extracellular ATP on synaptic transmission at the frog neuromuscular junction.
    Giniatullin A; Petrov A; Giniatullin R
    Neuroscience; 2015 Jan; 285():324-32. PubMed ID: 25463521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purine P2Y receptors in ATP-mediated regulation of non-quantal acetylcholine release from motor nerve endings of rat diaphragm.
    Malomouzh AI; Nikolsky EE; Vyskočil F
    Neurosci Res; 2011 Nov; 71(3):219-25. PubMed ID: 21821069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opposite modulation of astroglial proliferation by adenosine 5'-O-(2-thio)-diphosphate and 2-methylthioadenosine-5'-diphosphate: mechanisms involved.
    Quintas C; Fraga S; Gonçalves J; Queiroz G
    Neuroscience; 2011 May; 182():32-42. PubMed ID: 21419195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of purinergic P2Y
    Villanueva-Castillo B; Rivera-Mancilla E; Haanes KA; MaassenVanDenBrink A; Villalón CM
    Purinergic Signal; 2020 Mar; 16(1):73-84. PubMed ID: 32067141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADP acting on P2Y13 receptors is a negative feedback pathway for ATP release from human red blood cells.
    Wang L; Olivecrona G; Götberg M; Olsson ML; Winzell MS; Erlinge D
    Circ Res; 2005 Feb; 96(2):189-96. PubMed ID: 15604418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATP released together with acetylcholine as the mediator of neuromuscular depression at frog motor nerve endings.
    Redman RS; Silinsky EM
    J Physiol; 1994 May; 477(Pt 1):117-27. PubMed ID: 8071878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleotide P2Y13-stimulated phosphorylation of CREB is required for ADP-induced proliferation of late developing retinal glial progenitors in culture.
    Jacques FJ; Silva TM; da Silva FE; Ornelas IM; Ventura ALM
    Cell Signal; 2017 Jul; 35():95-106. PubMed ID: 28347874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excitatory effect of the A2A adenosine receptor agonist CGS-21680 on spontaneous and K+-evoked acetylcholine release at the mouse neuromuscular junction.
    Palma AG; Muchnik S; Losavio AS
    Neuroscience; 2011 Jan; 172():164-76. PubMed ID: 20971164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of rat hepatocyte function by P2Y receptors: focus on control of glycogen phosphorylase and cyclic AMP by 2-methylthioadenosine 5'-diphosphate.
    Dixon CJ; Hall JF; Webb TE; Boarder MR
    J Pharmacol Exp Ther; 2004 Oct; 311(1):334-41. PubMed ID: 15152027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of novel agonist selectivity for the ADP-activated P2Y1 receptor versus the ADP-activated P2Y12 and P2Y13 receptors by conformational constraint of an ADP analog.
    Chhatriwala M; Ravi RG; Patel RI; Boyer JL; Jacobson KA; Harden TK
    J Pharmacol Exp Ther; 2004 Dec; 311(3):1038-43. PubMed ID: 15345752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ATP modulates noradrenaline release by activation of inhibitory P2Y receptors and facilitatory P2X receptors in the rat vas deferens.
    Queiroz G; Talaia C; Gonçalves J
    J Pharmacol Exp Ther; 2003 Nov; 307(2):809-15. PubMed ID: 12966150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.